一个病例报告,一名患有便秘的儿童被诊断为获得的肌肠性低结核病
Niharika Singh1, James Petrancosta1, Elizabeth O'Daniel2
1Department of Surgery, Stony Brook University Hospital, Stony Brook, NY 11794, USA.
Reports (MDPI)
|July 23, 2025
概括
获得的肌肠性海波腺炎是儿童严重便秘的罕见原因. 早期怀疑对于诊断和管理这种胃肠道动力障碍至关重要.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 胃肠道运动障碍 胃肠道运动障碍
- 神经病理学神经病理学
背景情况:
- 获得的肌肠性低结核病是一种罕见的动力障碍疾病,其特征在于Auerbach's plexus中的结细胞减少.
- 在青少年中,很少有获得的肌肠性海波甘病的病例被记录在案.
- 本报告详细介绍了一个案例,以探索表现,风险因素和手术并发症.
相关概念视频
Gastrointestinal Motility Disorders
602
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
602
Assessment of the Rectum and Anus
410
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
410
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
250
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
250
Drugs for Treatment of Constipation-Predominant IBS
342
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
342
Irritable Bowel Syndrome I: Introduction
392
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
392
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
405
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
405


